Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
+590K
-
Total reported value, excl. options
-
$1.18B
-
Value change
-
+$27.6M
-
Put/Call ratio
-
0.43
-
Number of buys
-
54
-
Number of sells
-
-46
-
Price
-
$42.10
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q1 2015
119 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q1 2015.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 374M outstanding shares and own 7.47% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (3.73M shares), JENNISON ASSOCIATES LLC (3.03M shares), FRANKLIN RESOURCES INC (2.16M shares), ORBIMED ADVISORS LLC (2.14M shares), WASATCH ADVISORS INC (2.05M shares), LORD, ABBETT & CO. LLC (1.59M shares), NEXT CENTURY GROWTH INVESTORS LLC (1.35M shares), FMR LLC (1.15M shares), VANGUARD GROUP INC (948K shares), and RS INVESTMENT MANAGEMENT CO LLC (909K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.